Harold Berger, Director at Cryo-Cell International (AMEX:CCEL), reported a large acquisition of company stock options on October 12, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Berger, Director at Cryo-Cell International, a company in the Health Care sector, was just awarded stock options worth 5,300 shares of CCEL. The options give Berger the right to buy the company's stock at $4.9 per share.
Cryo-Cell International shares are trading down 0.0% at $5.04 at the time of this writing on Friday morning. Since the current price is $5.04, this makes Berger's 5,300 shares worth $26,712.